DexCom Non-GAAP EPS of $0.34 beats by $0.06, revenue of $815.2M in-line
DexCom press release  (NASDAQ:DXCM): Q4  Non-GAAP EPS of $0.34  beats by $0.06.
Revenue of $815.2M (+16.8% Y/Y) in-line.
2023 Annual Guidance
The company is reiterating guidance for fiscal year 2023 revenue, Non-GAAP Gross Profit Margin, and Non-GAAP Operating Margin, and establishing guidance for Adjusted EBITDA Margin at the following levels:
Revenue of approximately $3.35 - 3.49 billion vs $3.46B consensus (15-20% growth)
Non-GAAP Gross Profit Margin of 62-63%
Non-GAAP Operating Margin of approximately 16.5%
Adjusted EBITDA Margin of approximately 26%